Press Releases from DelveInsight Business Research LLP (4751 total)
Chronic Hepatitis B Virus Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Chronic Hepatitis B Virus Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Chronic Hepatitis B Virus pipeline…
Cholangiocarcinoma Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Cholangiocarcinoma Pipeline Insight 2024" report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Cholangiocarcinoma pipeline landscape. It covers the Cholangiocarcinoma pipeline…
Cervical Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Cervical Cancer Pipeline Insight 2024" report provides comprehensive insights about 70+ companies and 70+ pipeline drugs in Cervical Cancer pipeline landscape. It covers the…
Brain Metastases Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Brain Metastases Pipeline Insight 2024" report provides comprehensive insights about 40+ Brain Metastases companies and 45+ pipeline drugs in the Brain Metastases pipeline landscape.…
Acute Respiratory Distress Syndrome Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Acute Respiratory Distress Syndrome Pipeline Insight, 2024," report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Acute Respiratory Distress Syndrome pipeline…
Wet Age-Related Macular Degeneration Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Wet Age-Related Macular Degeneration (Wet-AMD) Pipeline Insight, 2024" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Wet Age-Related Macular Degeneration…
Ulcerative Colitis Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Ulcerative Colitis Pipeline Insight 2024" report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Ulcerative Colitis (UC) pipeline landscape. It covers…
Type 1 Diabetes Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Type 1 Diabetes Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Type 1 Diabetes pipeline landscape.…
Triple Negative Breast Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Triple Negative Breast Cancer Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Triple Negative Breast Cancer pipeline…
TCR Therapy Pipeline Outlook Report 2024
DelveInsight's, "TCR Therapy Pipeline Insight 2024" report provides comprehensive insights about 30+ companies and 100+ pipeline drugs in the TCR Therapy pipeline landscape. It covers…
T-Cell Lymphoma Pipeline Outlook Report 2024
DelveInsight's, "T-Cell Lymphoma Pipeline Insight 2024" report provides comprehensive insights about 90+ companies and 90+ pipeline drugs in T-Cell Lymphoma pipeline landscape. It covers the…
Soft Tissue Sarcoma Pipeline Outlook Report 2024
DelveInsight's, "Soft Tissue Sarcoma Pipeline Insight 2024" report provides comprehensive insights about 125+ companies and 130+ pipeline drugs in Soft Tissue Sarcoma pipeline landscape. It…
Small lymphocytic lymphoma Pipeline Outlook Report 2024
DelveInsight's, "Small Lymphocytic Lymphoma Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in Small Lymphocytic Lymphoma pipeline landscape. It…
Small Cell Lung Cancer Pipeline Outlook Report 2024
DelveInsight's, "Small Cell Lung Cancer Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Small Cell Lung Cancer…
Rheumatoid Arthritis Pipeline Outlook Report 2024
DelveInsight's, "Rheumatoid Arthritis Pipeline Insight 2024" report provides comprehensive insights about 95+ companies and 100+ pipeline drugs in the Rheumatoid Arthritis pipeline landscape. It covers…
Renal Cell Carcinoma Pipeline Outlook Report 2024
DelveInsight's, "Renal Cell Carcinoma Pipeline Insight 2024" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Renal Cell Carcinoma pipeline landscape. It…
Powered Surgical Instruments Market to Showcase Growth in the Upcoming Years | S …
The global market for powered surgical instruments reached a value of USD 2.06 billion in 2021 and is projected to expand at a compound annual…
Renal Cancer Pipeline Outlook Report 2024
DelveInsight's, "Renal Cancer Pipeline Insight 2024" report provides comprehensive insights about 75+ Renal Cancer companies and 80+ pipeline drugs in the Renal Cancer pipeline landscape.…
Orthopedic Prosthesis Devices Market to Showcase Growth in the Upcoming Years | …
The worldwide market for orthopedic prosthesis devices reached a valuation of USD 2.22 billion in 2021 and is projected to expand at a compound annual…
Burn Pain Market to Show a Rise During the Study Period | MediWound Germany GmbH …
DelveInsight's "Burn Pain Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Burn Pain, historical and forecasted epidemiology as well as…
Chemotherapy-induced Hearing Loss Market to Show a Rise During the Study Period …
DelveInsight's "Chemotherapy-induced Hearing Loss Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chemotherapy-induced Hearing Loss, historical and foreacasted epidemiology as…
Chiari Malformation Market to Show a Rise During the Study Period | Pfizer Inc., …
DelveInsight's "Chiari Malformation Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chiari Malformation, historical and forecasted epidemiology as well as…
Relapsed/Refractory Acute Myeloid Leukemia Pipeline Outlook Report 2024
DelveInsight's, "Relapsed/refractory acute myeloid leukemia (AML) Pipeline Insight, 2024" report provides comprehensive insights about 50+ companies and 75+ pipeline drugs in Relapsed/refractory acute myeloid leukemia…
Refractory Multiple Myeloma Pipeline Outlook Report 2024
elveInsight's, "Refractory Multiple Myeloma Pipeline Insight, 2024," report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Refractory Multiple Myeloma pipeline landscape. It…
The Market share for VX15 (Pepinemab) by Vaccinex, Inc. Set to Experience Tremen …
[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on VX15 (Pepinemab) (Vaccinex, Inc.) providing insights…
Giredestrant by Genentech expected to drive market size of ER+ve HER2-ve Breast …
[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on Giredestrant (Genentech) providing insights into the…
Chronic Liver Disease Market to Show a Rise During the Study Period | Abbott Lab …
DelveInsight's "Chronic Liver Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chronic Liver Disease, historical and forecasted epidemiology as…
Clear Cell Carcinoma Market to Show a Rise During the Study Period |F. Hoffmann- …
DelveInsight's "Clear Cell Carcinoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Clear Cell Carcinoma, historical and forecasted epidemiology as…
CNS Lymphoma Market to Show a Rise During the Study Period | Shandong New Time P …
DelveInsight's "CNS Lymphoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the CNS Lymphoma, historical and forecasted epidemiology as well as…
Community-Acquired Bacterial Pneumonia Market to Show a Rise During the Study Pe …
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as…
Chronic Hemodialysis Market to Show a Rise During the Study Period | Fresenius M …
DelveInsight's "Chronic Hemodialysis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chronic Hemodialysis, historical and forecasted epidemiology as well as…
Chronic Brain Damage Market to Show a Rise During the Study Period | NeuroVive P …
DelveInsight's "Chronic Brain Damage Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chronic Brain Damage, historical and forecasted epidemiology as…
Pancreatic Ductal Adenocarcinoma Pipeline Outlook Report 2024 | Alligator Biosci …
DelveInsight's, "Pancreatic Ductal Adenocarcinoma Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in Pancreatic Ductal Adenocarcinoma pipeline landscape. It…
Osteoarthritis Pipeline Outlook Report 2024 | Biosplice Therapeutics, Gilead Sci …
DelveInsight's, "Osteoarthritis Pipeline Insight 2024" report provides comprehensive insights about 130+ companies and 130+ pipeline drugs in the Osteoarthritis pipeline landscape. It covers the Osteoarthritis…
Ocular Hypertension Pipeline Outlook Report 2024 | Nicox, Qlaris Bio, TheratOcul …
DelveInsight's, "Ocular Hypertension Pipeline Insight 2024" report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in the Ocular Hypertension pipeline landscape. It covers…
Obesity Pipeline Outlook Report 2024 | Aardvark Therapeutics, Adocia, Agentix, A …
DelveInsight's, "Obesity Pipeline Insight 2024" report provides comprehensive insights about 100+ Obesity companies and 130+ Obesity pipeline drugs in the Obesity pipeline landscape. It covers…
Non Alcoholic Fatty Liver Disease Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Non-Alcoholic Fatty Liver Disease Pipeline Insight 2023" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Non-Alcoholic Fatty Liver Disease…
NK Cell Therapy Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "NK Cell Therapy Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 185+ pipeline drugs in NK Cell Therapy pipeline landscape. It…
Myelodysplastic Syndrome Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Myelodysplastic Syndrome Pipeline Insight 2024" report provides comprehensive insights about 120+ companies and 150+ pipeline drugs in Myelodysplastic Syndrome pipeline landscape. It covers the…
Multiple Sclerosis Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Multiple Sclerosis Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Multiple sclerosis pipeline landscape. It covers…
Multiple Myeloma Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Multiple Myeloma Pipeline Insights 2024" report provides comprehensive insights about 75+ Multiple Myeloma Companies and 80+ pipeline drugs in the Multiple Myeloma pipeline landscape.…
Metastatic Melanoma Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Metastatic Melanoma Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Metastatic Melanoma pipeline landscape. It covers…
Metastatic Colorectal Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Metastatic Colorectal Cancer Pipeline Insight 2024" report provides comprehensive insights about 130+ companies and 140+ pipeline drugs in the Metastatic Colorectal Cancer pipeline landscape.…
Metastatic Castration-Resistant Prostate cancer Pipeline Outlook Report 2024 (Up …
DelveInsight's, "Metastatic Castration-Resistant Prostate Cancer Pipeline Insight 2023" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Metastatic Castration-Resistant Prostate Cancer…
Metastatic Breast Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Metastatic Breast Cancer Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Metastatic Breast Cancer pipeline landscape.…
Major Depressive Disorder Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Major Depressive Disorder Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Major Depressive Disorder pipeline landscape.…
Liver Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Liver Cancer Pipeline Insight 2024" report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Liver Cancer pipeline landscape. It covers the…
Influenza Pipeline Outlook, Clinical Trials, and Emerging Therapies Report 2024
The Influenza Pipeline Insight 2024 report by DelveInsight offers a thorough global overview of Influenza treatments, including those already in the market, as well as…
Idiopathic Pulmonary Fibrosis Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Idiopathic Pulmonary Fibrosis Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Idiopathic Pulmonary Fibrosis pipeline landscape.…
Hypertension Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Hypertension Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Hypertension pipeline landscape. It covers the Hypertension…
